ID

33350

Description

A Study of R1507 in Combination With Letrozole in Postmenopausal Women With Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00796107

Link

https://clinicaltrials.gov/show/NCT00796107

Keywords

  1. 12/6/18 12/6/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

December 6, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Cancer NCT00796107

Eligibility Breast Cancer NCT00796107

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
postmenopausal female patients;
Description

Postmenopausal state

Data type

boolean

Alias
UMLS CUI [1]
C0232970
stage iv or locally advanced breast cancer;
Description

Secondary malignant neoplasm of female breast | Locally advanced breast cancer

Data type

boolean

Alias
UMLS CUI [1]
C0346993
UMLS CUI [2]
C3495949
measurable disease;
Description

Measurable Disease

Data type

boolean

Alias
UMLS CUI [1]
C1513041
letrozole failure (part 2);
Description

Letrozole failed

Data type

boolean

Alias
UMLS CUI [1,1]
C0246421
UMLS CUI [1,2]
C0231175
ecog performance status <=2.
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous chemotherapy for metastatic breast cancer;
Description

Prior Chemotherapy Secondary malignant neoplasm of female breast

Data type

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0346993
concurrent antibody or immunotherapy for advanced disease, within 4 weeks prior to receipt of study drug;
Description

Antibody therapy Advanced disease | Immunotherapy Advanced disease

Data type

boolean

Alias
UMLS CUI [1,1]
C0281176
UMLS CUI [1,2]
C0679246
UMLS CUI [2,1]
C0021083
UMLS CUI [2,2]
C0679246
history of primary malignancy in 5 years prior to study, excluding adequately treated basal or squamous cell cancer of skin, or cancer in situ of cervix;
Description

Primary tumor | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated | Exception Carcinoma in situ of uterine cervix

Data type

boolean

Alias
UMLS CUI [1]
C0677930
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007117
UMLS CUI [2,3]
C1522326
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0553723
UMLS CUI [3,3]
C1522326
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0851140
concurrent radiotherapy, or radiotherapy within 28 days prior to receipt of study drug.
Description

Therapeutic radiology procedure

Data type

boolean

Alias
UMLS CUI [1]
C1522449

Similar models

Eligibility Breast Cancer NCT00796107

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Postmenopausal state
Item
postmenopausal female patients;
boolean
C0232970 (UMLS CUI [1])
Secondary malignant neoplasm of female breast | Locally advanced breast cancer
Item
stage iv or locally advanced breast cancer;
boolean
C0346993 (UMLS CUI [1])
C3495949 (UMLS CUI [2])
Measurable Disease
Item
measurable disease;
boolean
C1513041 (UMLS CUI [1])
Letrozole failed
Item
letrozole failure (part 2);
boolean
C0246421 (UMLS CUI [1,1])
C0231175 (UMLS CUI [1,2])
ECOG performance status
Item
ecog performance status <=2.
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prior Chemotherapy Secondary malignant neoplasm of female breast
Item
previous chemotherapy for metastatic breast cancer;
boolean
C1514457 (UMLS CUI [1,1])
C0346993 (UMLS CUI [1,2])
Antibody therapy Advanced disease | Immunotherapy Advanced disease
Item
concurrent antibody or immunotherapy for advanced disease, within 4 weeks prior to receipt of study drug;
boolean
C0281176 (UMLS CUI [1,1])
C0679246 (UMLS CUI [1,2])
C0021083 (UMLS CUI [2,1])
C0679246 (UMLS CUI [2,2])
Primary tumor | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated | Exception Carcinoma in situ of uterine cervix
Item
history of primary malignancy in 5 years prior to study, excluding adequately treated basal or squamous cell cancer of skin, or cancer in situ of cervix;
boolean
C0677930 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0553723 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0851140 (UMLS CUI [4,2])
Therapeutic radiology procedure
Item
concurrent radiotherapy, or radiotherapy within 28 days prior to receipt of study drug.
boolean
C1522449 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial